EE261 Cost-Effectiveness of Mixed-Approach Maternal RSVpreF/Infant Nirsevimab Immunization vs. Nirsevimab Alone for Prevention of Respiratory Syncytial Virus in Spain
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.645
https://www.valueinhealthjournal.com/article/S1098-3015(25)03202-4/fulltext
Title :
EE261 Cost-Effectiveness of Mixed-Approach Maternal RSVpreF/Infant Nirsevimab Immunization vs. Nirsevimab Alone for Prevention of Respiratory Syncytial Virus in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03202-4&doi=10.1016/j.jval.2025.09.645
First page :
Section Title :
Open access? :
No
Section Order :
10229